| Product Code: ETC6852110 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Croatia import of gemcitabine hydrochloride saw a shift in concentration levels from high to moderate in 2024, with top exporting countries being India, Germany, Italy, Spain, and Japan. The compound annual growth rate (CAGR) for the period 2020-2024 was at -19.81%, while the growth rate from 2023 to 2024 experienced a decline of -35.36%. This trend indicates a fluctuating market dynamic for gemcitabine hydrochloride imports in Croatia, with potential opportunities for diversification and strategic partnerships in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Croatia Gemcitabine Hydrochloride Market Overview |
3.1 Croatia Country Macro Economic Indicators |
3.2 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, 2021 & 2031F |
3.3 Croatia Gemcitabine Hydrochloride Market - Industry Life Cycle |
3.4 Croatia Gemcitabine Hydrochloride Market - Porter's Five Forces |
3.5 Croatia Gemcitabine Hydrochloride Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Croatia Gemcitabine Hydrochloride Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Croatia Gemcitabine Hydrochloride Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Croatia |
4.2.2 Growing awareness about the benefits of gemcitabine hydrochloride in cancer treatment |
4.2.3 Rising healthcare expenditure and government initiatives to improve cancer care |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from alternative cancer treatment options |
4.3.3 Pricing pressure due to the presence of generic versions of gemcitabine hydrochloride |
5 Croatia Gemcitabine Hydrochloride Market Trends |
6 Croatia Gemcitabine Hydrochloride Market, By Types |
6.1 Croatia Gemcitabine Hydrochloride Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, By Injection, 2021- 2031F |
6.1.4 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, By Solution, 2021- 2031F |
6.2 Croatia Gemcitabine Hydrochloride Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, By Non-small Cell Lung Cancer, 2021- 2031F |
6.2.4 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.5 Croatia Gemcitabine Hydrochloride Market Revenues & Volume, By Others, 2021- 2031F |
7 Croatia Gemcitabine Hydrochloride Market Import-Export Trade Statistics |
7.1 Croatia Gemcitabine Hydrochloride Market Export to Major Countries |
7.2 Croatia Gemcitabine Hydrochloride Market Imports from Major Countries |
8 Croatia Gemcitabine Hydrochloride Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Croatia |
8.2 Adoption rate of gemcitabine hydrochloride in cancer treatment |
8.3 Research and development investment in improving gemcitabine hydrochloride formulations |
9 Croatia Gemcitabine Hydrochloride Market - Opportunity Assessment |
9.1 Croatia Gemcitabine Hydrochloride Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Croatia Gemcitabine Hydrochloride Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Croatia Gemcitabine Hydrochloride Market - Competitive Landscape |
10.1 Croatia Gemcitabine Hydrochloride Market Revenue Share, By Companies, 2024 |
10.2 Croatia Gemcitabine Hydrochloride Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |